Antigua and Barbuda vs Sur: New cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2024
Sur
97.0%
in 2024
Antigua and Barbuda rank
1st
Sur rank
2nd
New cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Sur
How they compare
Antigua and Barbuda currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 1 time across 12 shared years of data; in 2009 it was Sur ahead.
Antigua and Barbuda ranks 1st and Sur ranks 2nd of 192 countries.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.7% | 0.7% | Sur |
| 2010s | 0.0% | 54.2% | 54.2% | Sur |
| 2020s | 33.3% | 97.7% | 64.3% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Antigua and Barbuda or Sur?
- Antigua and Barbuda, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Antigua and Barbuda and Sur?
- 3.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Sur?
- 12 years are reported by both, from 2009 to 2024.
- How do Antigua and Barbuda and Sur rank globally for new cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Sur ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.